Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Re: "Botulinum toxin type a injection without isopropyl alcohol antisepsis".

O'Neill J, Grinager HS, Harrison AR, Lee MS.

Ophthal Plast Reconstr Surg. 2012 Jul-Aug;28(4):307-8; author reply 308. doi: 10.1097/IOP.0b013e31825ca776. No abstract available.

PMID:
22785595
2.

Botulinum toxin type A injection without isopropyl alcohol antisepsis.

Pham T, Perry JD.

Ophthal Plast Reconstr Surg. 2009 May-Jun;25(3):178-9. doi: 10.1097/IOP.0b013e3181a145e5.

PMID:
19454925
3.

Isopropyl alcohol skin antisepsis does not reduce incidence of infection following insulin injection.

O'Neill J, Grinager H, Smith SD, Sibley S, Harrison AR, Lee MS.

Am J Infect Control. 2013 Aug;41(8):755-6. doi: 10.1016/j.ajic.2012.11.009. No abstract available.

PMID:
23419612
4.

A simplified technique for botulinum toxin injections in children with neurogenic bladder.

Pascali MP, Mosiello G, Marciano A, Capitanucci ML, Zaccara AM, De Gennaro M.

J Urol. 2011 Jun;185(6 Suppl):2558-62. doi: 10.1016/j.juro.2011.01.037.

PMID:
21527204
5.

Eyelid botulinum toxin injections for the dry eye.

Sahlin S, Linderoth R.

Dev Ophthalmol. 2008;41:187-92. doi: 10.1159/000131089. Review.

PMID:
18453769
6.

Gummy smile and botulinum toxin: a new approach based on the gingival exposure area.

Mazzuco R, Hexsel D.

J Am Acad Dermatol. 2010 Dec;63(6):1042-51. doi: 10.1016/j.jaad.2010.02.053.

PMID:
21093661
7.

Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.

Xiao L, Mackey S, Hui H, Xong D, Zhang Q, Zhang D.

Pain Med. 2010 Dec;11(12):1827-33. doi: 10.1111/j.1526-4637.2010.01003.x.

PMID:
21134121
8.

Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.

Beer KR, Wilson F.

Dermatol Surg. 2011 Jun;37(6):870-2. doi: 10.1111/j.1524-4725.2011.01851.x. No abstract available.

PMID:
21605254
9.

Commentary: The effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan.

Ahn KY.

Dermatol Surg. 2010 Dec;36 Suppl 4:2167. doi: 10.1111/j.1524-4725.2010.01799.x. No abstract available.

PMID:
21244566
10.

Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?

Kapoor R, Shome D, Jain V, Dikshit R.

Dermatol Surg. 2010 Dec;36 Suppl 4:2098-105. doi: 10.1111/j.1524-4725.2010.01703.x.

PMID:
21134041
11.

Use of a transparent dressing in the treatment of axillary hyperhidrosis with botulinum toxin type A.

Galán-Gutiérrez M, Garnacho-Saucedo G, Salido-Vallejo R, Vélez Garcia-Nieto A, Moreno-Giménez JC.

J Am Acad Dermatol. 2010 Dec;63(6):e111-2. doi: 10.1016/j.jaad.2010.03.018. No abstract available.

PMID:
21093655
12.

Effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan.

Shim WH, Yoon SH, Park JH, Choi YC, Kim ST.

Dermatol Surg. 2010 Dec;36 Suppl 4:2161-6. doi: 10.1111/j.1524-4725.2010.01704.x. Erratum in: Dermatol Surg. 2011 Feb;37(2):294.

PMID:
21134047
13.

Commentary: Efficacy and safety of a novel botulinum toxin topical gel.

West TB.

Dermatol Surg. 2010 Dec;36 Suppl 4:2119-20. doi: 10.1111/j.1524-4725.2010.01796.x. No abstract available.

PMID:
21244565
14.

Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.

Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM, Cruz C, Cruz F, Dinis P.

Eur Urol. 2010 Sep;58(3):360-5. doi: 10.1016/j.eururo.2010.02.031.

PMID:
20227820
15.

Safety of botulinum toxin for the treatment of children with chronic anal fissure.

Khout H, Kadi N.

Eur J Pediatr Surg. 2010 Nov;20(6):412. doi: 10.1055/s-0030-1263196. No abstract available.

PMID:
21181607
16.

Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.

Sattler G, Callander MJ, Grablowitz D, Walker T, Bee EK, Rzany B, Flynn TC, Carruthers A.

Dermatol Surg. 2010 Dec;36 Suppl 4:2146-54. doi: 10.1111/j.1524-4725.2010.01706.x.

PMID:
21134045
17.

Botulinum toxin type a headache treatment and entrapment of the supratrochlear nerve.

Saers SJ, de Ru JA.

Arch Dermatol. 2010 Nov;146(11):1310-1; author reply 1311. doi: 10.1001/archdermatol.2010.312. No abstract available.

PMID:
21079079
18.

Botulinum toxin and urinary bladder disorders in women: new insight into an old problem.

Kocjancic E, Rizk DE.

Int Urogynecol J. 2010 Jun;21(6):619-21. doi: 10.1007/s00192-010-1136-y. No abstract available.

PMID:
20358176
19.

Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.

Brandt F.

Dermatol Surg. 2011 Jul;37(7):1060. doi: 10.1111/j.1524-4725.2011.02067.x. No abstract available.

PMID:
21711409
20.

Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.

Brandt F, O'Connell C, Cazzaniga A, Waugh JM.

Dermatol Surg. 2010 Dec;36 Suppl 4:2111-8. doi: 10.1111/j.1524-4725.2010.01711.x.

PMID:
21134043

Supplemental Content

Support Center